Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis

NCT07202598 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT07202598
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07202598 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomized Stepped Wedge Study of Emapalumab in APECED Enteritis
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 2
Overall status
Recruiting
Start date
November 12, 2025
Completion date
September 1, 2031
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune polyendocrinopathy candidiasis ectodermal dystrophy enteritis